Risk of Inflammatory CNS Diseases After TNF Inhibitor Treatment for Autoimmune Diseases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Risk of Inflammatory Central Nervous System Diseases After Tumor Necrosis Factor-Inhibitor Treatment for Autoimmune Diseases: A Systematic Review and Meta-Analysis
JAMA Neurol 2024 Oct 21;[EPub Ahead of Print], W Xie, Y Sun, W Zhang, N Zhu, S XiaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.